Search This Blog

Friday, May 3, 2013

Allergan CEO: FDA Voted In Favor of Voluma

Allergan reported positive earnings on Wednesday, but the stock tumbled after. Its CEO David Pyott discusses earnings, drug delays and the future of the company.

Video (8:50)

Allergan CEO: FDA Voted In Favor of Voluma

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.